GTC presented abstracts at the 2025 Annual Meeting of the Society for Neuro-Oncology (SNO).
GTC participated in the 30th Annual Meeting & Education Day of the Society for Neuro-Oncology (SNO), held at the Hawaii Convention Center in Honolulu, November 19–23, 2025. Our two presented posters are now available for download. For scientific clarification or collaboration inquiries, please contact us directly.
Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors - Abstract Code: INNV-08
Monitoring therapy in leptomeningeal carcinomatosis in colorectal cancer using CSF liquid biopsy.- Abstract Code: BIOM40
Read more Articles and News from GTC
GTC and Dr. Maher Albitar Featured in Houston Business Journal
Genomic Testing Cooperative and its founder and CEO, Dr. Maher Albitar, were recently featured in the Houston Business Journal in a “Face to Face” profile highlighting
ASCO 2026 Abstracts
2026 ASCO Annual Meeting Here is the lineup of posters we are presenting at ASCO. Visit us at booth 17146 to discuss in further detail or
GTC opens Houston laboratory, expanding national precision oncology network
New central U.S. location strengthens testing capacity and turnaround times while positioning GTC within the Texas Medical Center ecosystem HOUSTON — March 12, 2026 — Genomic